ArticleHarm reduction journal2025
Street ketamine use and differential risk of suicidality among adults in Taiwan.
Article in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionThe misuse of ketamine, a dissociative anesthetic, has surged sharply in popularity across East and Southeast Asia and Oceania. This study aimed to evaluate the association between recent patterns of ketamine use and the risk of suicide in northern Taiwan.
methodsIllicit ketamine users were recruited through network-based sampling from 2015 to 2017, along with a comparison group of individuals who never used ketamine. Data on sociodemographics, drug use history, psychiatric disorders, and suicide risk were collected by trained psychiatric nurses. Participants were categorized into three groups: non- (n = 132), past (no ketamine use for ≥ 1 year; n = 80), and recent users (use in the past year; n = 167). Suicide risk, assessed by six items in the Mini-International Neuropsychiatric Interview, was classified as "no," "low," or "middle/high." Polytomous logistic regression and multivariate analyses were applied for risk estimation.
resultsStreet ketamine users disproportionately experienced higher mental health disorders (e.g.,major depressive disorder), disadvantaged socioeconomic status, involvement in legal issues, and lifetime suicide attempts (25%). The prevalence of middle to high suicide risk was notably higher among recent (10.8%) and past (5.0%) ketamine users, compared with people who had no ketamine use history. Past-month suicidality was four times higher in recent users (95% CI 1.35-12.27) and 3.4 times higher in past users (95% CI 1.01-11.45). Excess risk associated with recent ketamine use manifested exclusively in suicidal ideation. DISCUSSION AND
conclusionsIllicit ketamine use is strongly linked to increased suicidality, especially among recent users. Even past users remain at higher risk, highlighting the importance of integrating suicide risk assessments and targeted interventions in community-based alcohol and drug services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.